Arabidopsis thaliana lacks the flavone biosynthetic pathway, probably because of a lack or low activity of a flavone synthase. To establish this biosynthetic pathway in Arabidopsis, we subjected this model plant to transformation with the parsley gene for flavone synthase type I (FNS-I). Transgenic seedlings expressing FNS-I were cultured in liquid medium with or without naringenin, and plant extracts were then analyzed by high-performance liquid chromatography. In contrast to wild-type seedlings, the transgenic seedlings accumulated substantial amounts of apigenin, which is produced from naringenin by FNS-I, and the apigenin level correlated with the abundance of FNS-I mRNA in three different transgenic lines. These results indicate that the FNS-I transgene produces a functional enzyme that catalyzes the conversion of naringenin to apigenin in Arabidopsis. These FNS-I transgenic lines should prove useful in investigating the in vivo functions of enzymes that mediate the synthesis of the wide variety of flavones found in other plants.
Flavonoids are major plant secondary metabolites, comprising more than 9,000 different compounds. They are synthesized by the phenylpropanoid pathway. 1) They exhibit a variety of biological functions in higher plants, including protection from ultraviolet radiation, flower coloration, and antimicrobial activity. 2) In addition, they have attracted much attention due to their beneficial properties with regard to human health and nutrition, such as antioxidant and anticancer activities. 3) Flavones constitute one of the largest subgroups of flavonoids derived from flavanones. They participate in interactions between plants and various other organisms, such as microbes and insects. 4) Apigenin is a major flavone. It has been shown to possess marked antiinflammatory, antioxidant, and anticarcinogenic properties. [5] [6] [7] Flavone synthesis in land plants is catalyzed by two different types of enzyme: an NADPH-and O 2 -dependent membrane-bound P 450 monooxygenase known as flavone synthase type II (FNS-II), which has been identified in a wide range of plant species, 8, 9) and a 2-oxoglutarate-and Fe 2þ -dependent soluble dioxygenase known as flavone synthase type I (FNS-I), which has been identified only in Apiaceae. The FNS-I gene has been cloned from Petroselinum crispum (parsley), and its ability to confer conversion of naringenin to apigenin has been confirmed in transformed yeast and Escherichia coli. [10] [11] [12] [13] [14] In the model plant Arabidopsis thaliana, various flavonoids, including flavonols, flavanols, and anthocyanins, have been identified, and genes encoding the enzymes required for flavonoid synthesis have been isolated and characterized, [15] [16] [17] but flavones have not been detected in Arabidopsis, and this plant species is thought not to possess the flavone biosynthetic pathway due to lack of an enzyme equivalent to FNS-I or -II in its genome. 4) With respect to the pathway from phenylalanine to flavonone (naringenin), all enzymes responsible for each conversion step have been identified and well characterized.
18) It is thought that flavanone is consumed as a substrate in the biosynthesis of flavonols and anthocyanins. 18) Hence we hypothesized that the introduction of an FNS gene into Arabidopsis would render it a useful host for characterization of exogenous enzyme genes that contribute to the production of various flavone derivatives, especially those found in medicinal plants.
In the present study, we transformed Arabidopsis with an expression vector for the FNS-I gene of parsley. The transformed plants mediated efficient conversion of naringenin to apigenin in vivo, as revealed by a naringenin-feeding assay. Here we describe the introduction of the flavone biosynthetic pathway into Arabidopsis.
Materials and Methods
Chemicals. Naringenin (5, 7, 4 0 -trihydroxyflavanone) and apigenin (5, 7, 4 0 -trihydroxyflavone) were obtained y To whom correspondence should be addressed. Tel: +81-89-927-8274; Fax: +81-89-927-8276; E-mail: tozaway@ccr.ehime-u.ac.jp from Sigma-Aldrich Japan (Tokyo). Acetonitrile and formic acid for high-performance liquid chromatography (HPLC) were obtained from Nacalai Tescque (Kyoto, Japan) and Wako (Tokyo), respectively. All other reagents were of analytical grade.
Plant materials and growth conditions. Arabidopsis thaliana ecotype Columbia was used in transformation. Seeds were sown on soil and stratified at 4 C for 3 d before transfer to a growth chamber maintained under long-day (16-h light, 8-h dark) conditions. Temperature and humidity were maintained at 23 C and 50%.
Vector construction. A DNA fragment including the -glucuronidase (GUS) gene and the terminator of the nopaline synthase gene (nos) was excised from pBI101.1 (GenBank accession no. U12639) 19) with restriction enzymes HindIII and EcoRI, and both ends of the remaining plasmid were rendered blunt by treatment with the Klenow fragment, and then ligated. The resulting plasmid, which contains the nos promoter, the neomycin resistance gene, and the nos terminator between the right and left border sequences, was designated pYT102. Plasmid pBI221 (GenBank accession no. AF502128) was digested with SmaI and SacI to remove the GUS gene, and both ends of the remaining plasmid were ligated to an Sse8387I linker, prepared by hybridization of oligonucleotides 5 0 -CCTGCAG-GAGCT-3 0 and 5 0 -CCTGCAGG-3 0 , resulting in the generation of pYT103. Plasmid pYT102 was digested with PmeI, dephosphorylated with calf thymus alkaline phosphatase, and ligated to a blunted HindIII-EcoRI fragment, which was excised from pYT103. It contained the 35S promoter derived from the cauliflower mosaic virus and the nos terminator. The resulting plasmid was designated pYT105.
Cloning of the FNS-I gene and construction of an expression vector. Total RNA was prepared from parsley leaves by guanidinium thiocyanate-phenolchloroform extraction. 20) The RNA (1 mg) was subjected to reverse transcription with Thermo-script reverse transcriptase (Invitrogen, Carlsbad, CA) and an oligo(dT) 20 primer, and the resulting cDNA was used as a template to amplify a 1.1-kb DNA fragment containing the open reading frame (ORF) of the FNS-I gene by polymerase chain reaction (PCR) with primers PFNS1 (5 0 -AAAACTAGTATGGCTCCTA-CAACAATAACC-3 0 , SpeI site underlined) and PFNS2 (5 0 -AAAGTCGACCTAAGCTAAATTTTCATCTGC-3 0 , SalI site underlined). The amplified fragment was cloned into the SpeI and SalI sites of pEU3S 21) to yield pEU3S-FNS-I. The DNA sequence of the inserted fragment was identical to that of the P. crispum FNS-I gene determined previously (GenBank accession no. AY230247).
11) The Sse8387I fragment containing the ORF of FNS-I was excised from pEU3S-FNS-I and cloned into the Sse8387I site of the binary vector pYT105, resulting in the generation of pYT105-FNS-I.
Plant transformation. Binary vector pYT105-FNS-I was introduced into Agrobacterium tumefaciens strain C58C1 by the freeze-thaw method, 22) and transformation of A. thaliana (Columbia) by the resulting bacteria was performed by in planta infiltration. 23) Transformed seedlings (T 1 ) were identified by selection on solid MS medium (Murashige and Skoog plant salt mixture, Gamborg's B5 vitamin salt mixture, 1% sucrose, 0.05% MES buffer, pH 5.7, 0.8% agar) containing kanamycin (50 mg/l) and claforan (200 mg/l), and were then transferred to soil. Homozygous T 3 plants were used in further study.
Transgene analysis. Extraction of genomic DNA from Arabidopsis and PCR analysis were performed as described previously.
24) The FNS-I transgene was analyzed by PCR with primers PFNS1 and PFNS2 (described above). As a check on the quality of the genomic DNA, an internal fragment of the Arabidopsis arogenate dehydrogenase gene (GenBank accession no. AF434682) 25) was amplified with primers 5 0 -TGGAT-CGCAATTCGTGACGCATAC-3 0 and 5 0 -AAAGTCG-ACTTAAGATGATGATGATGATGATC-3 0 . For RNA analysis, total RNA was extracted from Arabidopsis transformants with an RNeasy Plant Mini Kit (Qiagen, Hilden, Germany), and 5 mg of the RNA was subjected to RNA gel-blot hybridization. A digoxigenin-labeled antisense RNA probe for the detection of FNS-I transcripts was prepared with a DIG RNA labeling kit (Roche, Mannheim, Germany). A 400-bp fragment of the FNS-I ORF (nucleotides 274 to 673) was amplified by PCR with primers PFNS3 (5 0 -AAAGAATTCTTT-GCTTTGCCTG-3 0 ) and PFNS4 (5 0 -CCCAAGCTT-TAATAGTACCTGG-3 0 ), and was then cloned into pSPT19 (Roche). The antisense RNA probe was synthesized from the resulting vector by in vitro run-off transcription with T7 RNA polymerase in the presence of digoxigenin-labeled UTP. RNA gel-blot hybridization was performed as described previously.
26)
Naringenin-feeding experiments. Seeds (1.5 mg) of wild-type and transgenic Arabidopsis were surfacesterilized with 20% (w/v) NaClO containing 0.01% Triton X-100 and then washed 5 times with sterilized water. The seeds were transferred to 100 ml of liquid MS medium (Murashige and Skoog plant salt mixture, Gamborg's B5 vitamin salt mixture, 1% sucrose, 0.05% MES, pH 5.7) and cultured under long-day conditions for 3 weeks in the absence or presence of 500 mM naringenin. The resulting seedlings were washed with distilled water three times, weighed, frozen in liquid nitrogen, and stored at À80 C until extraction of flavonoids.
HPLC analysis. Frozen Arabidopsis seedlings were homogenized in 5 ml of extraction solvent (50% meth-anol) per mg fresh weight (FW) with a Micro Smash MS-100R apparatus (Tomy, Tokyo), and then sonicated in an ultrasonic water bath at room temperature for 1 h. The resulting extract was centrifuged at 15;000 Â g for 5 min at 4 C, and the supernatant was then filtered through a 0.45-mm syringe filter before HPLC. The soluble extract (50 ml) was subjected to HPLC analysis with a Lachrom ELITE system (Hitachi, Tokyo) equipped with a YMC-Pack Pro C18 column (4.6 by 150 mm, 5 mm; YMC, Kyoto, Japan) and maintained at 35 C. Elution was performed at a flow rate of 1.0 ml/ min with an acetonitrile-water gradient as the mobile phase, both components containing 0.1% formic acid. Detection was performed with a photodiode array detector (L-2450, Hitachi) at wavelengths of 220 to 400 nm. The gradient conditions were as follows: 20 to 30% CH 3 CN over 50 min, followed by 95% CH 3 CN for 7 min. The absorbance at 290 and 340 nm was monitored for naringenin and apigenin respectively. Compound peaks were identified by comparison of the retention times and the ultraviolet-visible spectra of the samples with those of standard compounds. The data obtained by integration of the peaks for known amounts of standard were compared with the peak areas of the sample compounds for quantification.
Results and Discussion
Cloning of parsley FNS-I and its expression in Arabidopsis Evidence indicates that Arabidopsis does not possess the flavone biosynthetic pathway. 4) To establish this pathway in Arabidopsis (Fig. 1) , we introduced by Agrobacterium-mediated transformation an expression vector ( Fig. 2A) for parsley FNS-I, which has been found to manifest specific, efficient catalytic activity in the conversion of naringenin to apigenin when expressed in yeast and bacteria. 12, 13) Kanamycin-resistant transformed plants were selected, and the introduction of the FNS-I transgene was examined by PCR analysis of genomic DNA (Fig. 2B) . We obtained four independent homozygous lines (FA, FB, FC, FD) as T 3 plants. Accumulation of FNS-I transcripts in seedlings of these lines was verified by RNA gel-blot hybridization (Fig. 2C) , their abundance being greatest in the FB line, followed by the FA line. We detected no marked differences in morphology or growth rate between the four FNS-I homozygous lines and wild-type plants (data not shown), indicating that FNS-I expression, even at a high level, does not affect Arabidopsis development. We selected three independent lines, FA, FB, and FD, exhibiting different levels of FNS-I expression, for further investigation.
Function of FNS-I in transgenic plants
To clarify the activity of the FNS-I product in the transgenic lines, we attempted to measure the amount of apigenin in 21-d-old seedlings grown on MS agar plates. Wild-type plants grown under identical conditions were also analyzed as a control. Seedlings (100 mg FW) were extracted with 500 ml of 50% methanol, and 50 ml of the soluble extract was subjected to HPLC analysis, but we did not observe signals corresponding to naringenin or apigenin, and there were no apparent differences in the chromatograms between transformants expressing FNS-I and wild-type plants (Fig. 3A-D) . Biosynthesis of naringenin in the plant is tightly limited in tissues such as flowers. 4) Naringenin is also a precursor of various flavonoids, including anthocyanin in Arabidopsis. 18, 27) Therefore, it is likely that the limited amount of naringenin in the tested plants was immediately converted to compounds other than apigenin as a result of intrinsic enzyme activities, or that the level of naringenin accumulation was too low for detection of its conversion to apigenin by ectopically expressed FNS-I.
To overcome the limited availability of naringenin, we performed a naringenin-feeding experiment. Seedlings of the transgenic lines and wild-type plants were cultured in liquid MS medium in the absence or presence of 500 mM naringenin for 3 weeks. The seedlings were then subjected to extraction, followed by HPLC analysis. The HPLC profiles obtained for seedlings grown in liquid culture in the absence of naringenin did not differ from those observed for seedlings grown on naringenin-free MS agar plates (data not shown). In contrast, supplementation of the liquid medium with naringenin resulted in an accumulation of apigenin in the harvested plants, the amount of apigenin being markedly greater in the FNS-I lines than in the wild type (Fig. 3E-H) . The apigenin content of the transformants correlated with their accumulation of FNS-I transcripts (Fig. 2C) . The FA and FB lines, which showed the highest level of FNS-I expression, manifested apigenin levels of 139.7 and 190.0 mg/g FW respectively, whereas the FD line, which exhibited a low level of FNS-I expression, accumulated apigenin only to 11.2 mg/g FW, and showed a higher level of unconverted naringenin (Fig. 4) . These results indicate that the FNS-I transgene produces an active enzyme that efficiently catalyzes the conversion of naringenin to apigenin in transformed Arabidopsis plants.
The result of the naringenin-feeding experiment also indicates that exogenously supplemented naringenin was incorporated into Arabidopsis from the liquid culture medium during the 3-week period of the experiment. Naringenin production in wild-type Arabidopsis is limited to certain developmental stages due to control of the biosynthetic enzyme genes by developmental stage-specific transcription factors. 28, 29) Most of the incorporated naringenin appeared to be converted apigenin in the naringenin-fed FNS-I transgenic plants, and most of it remained unconverted in the wild-type plants, but we detected two unidentified small peaks (retention times, 22.1 and 34.5 min) in the naringeninfed transgenic plants that expressed high-level FNS-I mRNA (Fig. 3F, G) . Since these peaks were not observed in the naringenin-fed transgenic plants expressing low-level transgene or in the naringenin-fed wild-type plants, it is likely that these peaks originated from converted apigenin. It is probable that apigenin was converted to derivatives such as glyco-forms by intrinsic modification enzymes. Further investigation is necessary to identify these peaks.
We also observed that wild-type plants cultured in the medium containing naringenin did manifest a small apigenin-like peak (Fig. 3E) , corresponding to about 6.2 mg/g FW (Fig. 4) . Although no known types of FNS gene have been found in the genome sequence of Arabidopsis, this result suggests the involvement of an uncharacterized intrinsic enzyme that catalyzes an FNSlike reaction in the plant. The incorporation of naringenin probably occurred in a tissue-nonspecific manner in our feeding experiments, and hence it is also possible that an uncharacterized intrinsic enzyme converts naringenin to another compound, appearing as the apigenin-like peak in the HPLC profile, in tissues in which naringenin accumulation does not occur in normal plant development.
On the basis of our results, we conclude that it is possible to construct the flavone biosynthetic pathway in Arabidopsis by transformation with an exogenous gene encoding FNS-I. Our naringenin-feeding experiment demonstrated efficient conversion of naringenin to apigenin in the FNS-I transgenic plants. The transgenic lines generated in the present study might prove useful in in vivo analysis of various enzymes that contribute to the biosynthesis of flavone derivatives in other plant species, including medicinal plants, thereby providing a basis for metabolic engineering of specific flavonoid synthetic pathways. The naringenin and apigenin contents of wild-type and transgenic (T 3 ) seedlings cultured in MS liquid medium with and without 500 mM naringenin were determined from the areas of the corresponding peaks in HPLC profiles similarly to those shown in Fig. 3E -H. Data are expressed as mg per g FW, and are means AE SD of triplicates from a representative experiment. N.D., not detected.
